Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Entertainment
  • General
  • News
  • Top Stories

Is ‘The Gray Man’ The Next Netflix Franchise? Here’s How Many People Watched And What’s Next

By Chris Katje
July 27, 3:54 PM
One of the biggest hits for streaming platform Netflix Inc (NASDAQ: NFLX) in 2022 is being turned into a new franchise with plans for a sequel and spinoff. Here’s the details on the big budget spy movie “The Gray Man.”

NFLX

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • Markets

ICYMI: More Sustainability, Less Carbon: BMW Commits To Hemp And Recycling

By El Planteo
July 27, 3:34 PM
Encuentra nuestro contenido en Español en El Planteo: Manuela Castañeira, Candidata del Nuevo MAS: ‘Sobre el Cannabis Recreativo, Estuvo más Atinado L-Gante que la Derechista de Vidal’

BMWYY

Read More
1 minute read
  • General
  • News

Dollar General Plans Three New Distribution Centers With $480M Investment

By Shivani Kumaresan
July 27, 2:36 PM
Dollar General Corp (NYSE:DG) plans to build three new distribution centers in North Little Rock, Arkansas; Aurora, Colorado and Salem, Oregon.…

DG

Read More
1 minute read
  • General
  • News
  • Politics

U.S. Secretary Of State Blinken Says He Will Speak To Russian Foreign Minister Lavrov By Phone In Coming Days

By Benzinga Newsdesk
July 27, 2:33 PM
-Reuters

SPY

Read More
1 minute read
  • Buybacks
  • Earnings
  • Education
  • General
  • Guidance
  • News

Read How New Oriental Education Performed In Q4

By Shivani Kumaresan
July 27, 2:30 PM
New Oriental Education & Technology Group Inc (NYSE:EDU) reported a fourth-quarter FY22 sales decline of 56.8% year-on-year, to $524 million. The…

EDU

Read More
1 minute read
  • General
  • News
  • Politics

Russia Tells NASA It Plans To Stay On International Space Station At Least Until 2028, Four Years Longer Than Indicated In Earlier Announcement

By Benzinga Newsdesk
July 27, 2:14 PM
-Reuters

RSX

Read More
1 minute read
  • General
  • Guidance
  • News

Toyota Plans Additional Production Cuts In July

By Shivani Kumaresan
July 27, 2:14 PM
Toyota Motor Corp (NYSE:TM) has decided to cut domestic production by 4,000 vehicles in July. The company took the decision due…

TM

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Pfizer/BioNTech Start Phase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant

By Vandana Singh
July 27, 1:48 PM
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) initiated a randomized, active-controlled, observer-blind Phase 2 study to evaluate the safety, tolerability, and immune response…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Medicenna’s Lead Cancer Program Shows Preliminary Anti-Cancer Activity In Solid Tumor Study

By Vandana Singh
July 27, 1:42 PM
Medicenna Therapeutics Corp (NASDAQ:MDNA) announced new clinical data from the Phase 1/2 ABILITY study of MDNA11. The data provide preliminary evidence…

MDNA

Read More
1 minute read
  • General
  • Media
  • Trading Ideas

Wednesday’s CNBC Fast Money Halftime Report Mentions

By AJ Fabino
July 27, 1:34 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

AMZN

Posts pagination

Previous 1 … 2,287 2,288 2,289 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service